Forest Labs
Executive Summary
Firm announced Oct. 30 that it had entered into a licensing and distribution agreement with "a major U.S. pharmaceutical company" to market Forest's buccal nitroglycerine in the U.S. Forest said its partner "has one of the industry's largest field sales forces and is an outstanding marketer of cardiovascular products in the U.S.".